» Articles » PMID: 22012986

A Rare Variant at the KYNU Gene is Associated with Kynureninase Activity and Essential Hypertension in the Han Chinese Population

Overview
Date 2011 Oct 21
PMID 22012986
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Genetic studies in mouse and human suggest that kynureninase activity may influence blood pressure and renal function. The gene coding kynureninase (KYNU) is also located on chromosome band 2q14-q23, where a linkage peak for essential hypertension was previously detected in the Chinese Han population.

Methods And Results: After having found no association with common polymorphisms, this study aimed to assess the role of 1 rare variant of KYNU, Arg188Gln, and kynureninase activity in relation to hypertension. Thirty-three of 1124 Chinese patients with hypertension were heterozygous for Arg188Gln, whereas only 14 of 1084 normotensive controls were heterozygous for Arg188Gln (188G1n allele frequency, 0.015 versus 0.006; P=0.0075). A genotype-discordant sibling-pair study was performed in another 924 individuals from 213 families, indicating that 188G1n carriers had higher systolic blood pressure (168.29 ± 24.67 versus 139.00 ± 12.82 mm Hg, P<0.001) and diastolic blood pressure (105.50 ± 14.08 versus 90.75 ± 11.07 mm Hg, P=0.001) than did Arg188 homozygous siblings. The Arg188Gln variant was found to be rarer in 2 other ethnic groups (3 heterozygous among 880 hypertensive French whites and 0 of 90 black Africans with hypertension). The kynureninase activity in plasma was correlated with blood pressure in subjects from hypertensive families (P<0.05). The Kinetic Michaelis constants of 188Gln carriers was lower than that of Arg188 homozygous subjects (0.05 ± 0.02 versus 0.10 ± 0.02 mmol/L, P=0.005). Arg188Gln mutation in vitro also showed less catalytic efficiency than the wild-type KYNU enzyme (maximal reaction velocity/Kinetic Michaelis constant ratio, 0.050 ± 0.012 versus 0.11 ± 0.016 mL/min per mg; P=0.029).

Conclusions: The results show that the rare KYNU variant Arg188Gln affects kynureninase activity and are consistent with the hypothesis that this mutation can predispose to essential hypertension.

Citing Articles

Additive interaction of family medical history of cardiovascular diseases with hypertension and diabetes on the diagnosis of cardiovascular diseases among older adults in India.

Ahmed W, Dixit P, Halli S Front Cardiovasc Med. 2024; 11:1386378.

PMID: 39713213 PMC: 11659756. DOI: 10.3389/fcvm.2024.1386378.


Additive interaction of family medical history of diabetes with hypertension on the diagnosis of diabetes among older adults in India: longitudinal ageing study in India.

Ahmed W BMC Public Health. 2024; 24(1):999.

PMID: 38600575 PMC: 11005278. DOI: 10.1186/s12889-024-18146-0.


Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System.

Tanaka M, Szabo A, Spekker E, Polyak H, Toth F, Vecsei L Cells. 2022; 11(16).

PMID: 36010683 PMC: 9406499. DOI: 10.3390/cells11162607.


Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gestational diabetes mellitus.

Alur V, Raju V, Vastrad B, Tengli A, Vastrad C, Kotturshetti S Biosci Rep. 2021; 41(5).

PMID: 33890634 PMC: 8145272. DOI: 10.1042/BSR20210617.


The interaction on hypertension between family history and diabetes and other risk factors.

Li A, Peng Q, Shao Y, Fang X, Zhang Y Sci Rep. 2021; 11(1):4716.

PMID: 33633182 PMC: 7907071. DOI: 10.1038/s41598-021-83589-z.